• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期局部使用皮质类固醇后的停药效应。

Steroid Withdrawal Effects Following Long-term Topical Corticosteroid Use.

机构信息

From the Royal Randwick Medical Centre, New South Wales, Australia.

出版信息

Dermatitis. 2018 Jul/Aug;29(4):213-218. doi: 10.1097/DER.0000000000000387.

DOI:10.1097/DER.0000000000000387
PMID:29923852
Abstract

BACKGROUND

Concerns about topical steroid withdrawal (TSW) are leading some patients to cease long-term topical corticosteroid (TCS) therapy. Diagnostic criteria for this condition do not exist.

OBJECTIVE

The aim of this study was to examine the demographics and outcomes in adult patients who believe they are experiencing TSW following discontinuation of chronic TCS overuse.

METHODS

This was a retrospective cohort study of patients in an Australian general practice presenting with this clinical scenario between January 2015 and February 2018.

RESULTS

Women represented 56% of the 55 patients seen, and ages ranged from 20 to 66 years (mean, 32.9 years; median, 30.0 years). Seventy-six percent had an original diagnosis of atopic dermatitis. Sixty percent had used potent TCSs on the face, and 42% had a history of oral corticosteroid use for skin symptoms. Burning pain was reported in 65%; all had widespread areas of red skin; and so-called "elephant wrinkles," "red sleeve," and the headlight sign were seen in 56%, 40%, and 29%, respectively.

CONCLUSIONS

Patients with a history of long-term TCS overuse may experience symptoms and signs described in TSW on stopping TCSs. Diagnostic criteria, reflecting the histories and examination findings of the patients studied, are suggested in this article with the aim to advance discussion and research into TSW.

摘要

背景

由于担心局部皮质类固醇戒断(TSW),一些患者停止长期使用局部皮质类固醇(TCS)治疗。目前尚无该疾病的诊断标准。

目的

本研究旨在检查在停止长期 TCS 过度使用后,认为自己患有 TSW 的成年患者的人口统计学特征和结局。

方法

这是一项回顾性队列研究,研究对象为 2015 年 1 月至 2018 年 2 月期间在澳大利亚一家普通诊所出现这种临床情况的患者。

结果

55 名患者中女性占 56%,年龄在 20 至 66 岁之间(平均 32.9 岁;中位数 30.0 岁)。76%的患者最初诊断为特应性皮炎。60%的患者在面部使用强效 TCS,42%的患者有因皮肤症状口服皮质类固醇的病史。65%的患者报告有烧灼感;所有患者均有广泛的红斑;56%、40%和 29%的患者分别出现所谓的“象皮纹”、“红袖子”和“车头灯征”。

结论

长期 TCS 过度使用者在停止 TCS 后可能会出现 TSW 描述的症状和体征。本文提出了反映研究患者病史和检查结果的诊断标准,旨在推进 TSW 的讨论和研究。

相似文献

1
Steroid Withdrawal Effects Following Long-term Topical Corticosteroid Use.长期局部使用皮质类固醇后的停药效应。
Dermatitis. 2018 Jul/Aug;29(4):213-218. doi: 10.1097/DER.0000000000000387.
2
A systematic review of topical corticosteroid withdrawal ("steroid addiction") in patients with atopic dermatitis and other dermatoses.特应性皮炎和其他皮肤病患者局部皮质类固醇停药(“皮质类固醇成瘾”)的系统评价。
J Am Acad Dermatol. 2015 Mar;72(3):541-549.e2. doi: 10.1016/j.jaad.2014.11.024. Epub 2015 Jan 13.
3
Topical Steroid Withdrawal: A Case Series of 10 Children.局部皮质类固醇停药:10 例儿童病例系列。
Acta Derm Venereol. 2019 May 1;99(6):551-556. doi: 10.2340/00015555-3144.
4
Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation.停用皮质类固醇后使用外用他克莫司安全有效地治疗特应性皮炎中的难治性面部皮损。
Dermatology. 2001;203(1):32-7. doi: 10.1159/000051700.
5
Assessment of "corticophobia" as an indicator of non-adherence to topical corticosteroids: A pilot study.评估“皮质激素恐惧症”作为局部用皮质类固醇治疗不依从性指标的一项初步研究。
J Dermatolog Treat. 2017 Mar;28(2):104-111. doi: 10.1080/09546634.2016.1201189. Epub 2016 Jul 10.
6
Evaluation of the influence of family and friends, and the Internet on patient perceptions of long-term topical corticosteroid use.评估家人、朋友及互联网对患者长期外用糖皮质激素使用认知的影响。
J Dermatolog Treat. 2017 Nov;28(7):642-646. doi: 10.1080/09546634.2017.1306017. Epub 2017 Apr 16.
7
Steroid Phobia: A Review of Prevalence, Risk Factors, and Interventions.类固醇恐惧症:患病率、风险因素和干预措施的综述。
Am J Clin Dermatol. 2021 Nov;22(6):837-851. doi: 10.1007/s40257-021-00623-6. Epub 2021 Jul 21.
8
Topical corticosteroid addiction and withdrawal - An overview for GPs.外用糖皮质激素成瘾与戒断——全科医生概述
Aust Fam Physician. 2016 Jun;45(6):386-8.
9
Pregnancy outcomes after maternal exposure to topical corticosteroids: a UK population-based cohort study.母体暴露于局部皮质类固醇后的妊娠结局:一项英国基于人群的队列研究。
JAMA Dermatol. 2013 Nov;149(11):1274-80. doi: 10.1001/jamadermatol.2013.5768.
10
Transitioning from brand to generic with topical products and the importance of maintaining the formulation and therapeutic profiles of the original product: focus on clocortolone pivalate 0.1% cream.外用产品从品牌药向仿制药的转变以及维持原产品配方和治疗特性的重要性:聚焦于0.1%特戊酸氯泼尼醇乳膏
J Drugs Dermatol. 2014 Jul;13(7):s77-83.

引用本文的文献

1
Recommendations for Topical Corticosteroid Use and the Role of Alternative, Advanced Targeted Topical Treatments in the Treatment of Chronic Inflammatory Skin Diseases.外用糖皮质激素使用建议以及替代的、先进的靶向局部治疗在慢性炎症性皮肤病治疗中的作用。
J Clin Aesthet Dermatol. 2025 May-Jun;18(5-6 Suppl 1):S10-S13.
2
Breaking the cycle: a comprehensive exploration of topical steroid addiction and withdrawal.打破循环:局部类固醇成瘾与戒断的全面探索
Front Allergy. 2025 Mar 31;6:1547923. doi: 10.3389/falgy.2025.1547923. eCollection 2025.
3
Topical Steroid Withdrawal Is a Targetable Excess of Mitochondrial NAD.
局部类固醇戒断是线粒体烟酰胺腺嘌呤二核苷酸(NAD)过量的一个可靶向治疗的情况。
J Invest Dermatol. 2025 Feb 10. doi: 10.1016/j.jid.2024.11.026.
4
Topical Steroid Withdrawal in Atopic Dermatitis: Patient-reported Characterization from a Swedish Social Media Questionnaire.特应性皮炎的外用糖皮质激素撤药:来自瑞典社交媒体调查问卷的患者报告特征
Acta Derm Venereol. 2025 Jan 3;105:adv40187. doi: 10.2340/actadv.v105.40187.
5
Reviewing the Evidence Base for Topical Steroid Withdrawal Syndrome in the Research Literature and Social Media Platforms: An Evidence Gap Map.回顾研究文献和社交媒体平台中局部类固醇戒断综合征的证据基础:证据缺口图。
J Med Internet Res. 2024 Dec 6;26:e57687. doi: 10.2196/57687.
6
Investigating Topical Steroid Withdrawal Videos on TikTok: Cross-Sectional Analysis of the Top 100 Videos.调查 TikTok 上的局部用皮质类固醇戒断视频:前 100 个视频的横断面分析。
JMIR Form Res. 2024 Aug 29;8:e48389. doi: 10.2196/48389.
7
Characterization of Transcriptomic and Proteomic Changes in the Skin after Chronic Fluocinolone Acetonide Treatment.慢性氟轻松醋酸酯治疗后皮肤转录组和蛋白质组变化的特征。
Biomolecules. 2022 Dec 6;12(12):1822. doi: 10.3390/biom12121822.
8
The Effect and Mechanism of Burnet Gels on Steroid-Dependent Dermatitis in Guinea Pig Model.柏那特凝胶对豚鼠模型中类固醇依赖性皮炎的作用及机制。
Biomed Res Int. 2022 Sep 13;2022:5866824. doi: 10.1155/2022/5866824. eCollection 2022.
9
Steroid Phobia: Is There a Basis? A Review of Topical Steroid Safety, Addiction and Withdrawal.类固醇恐惧症:有依据吗?局部用皮质类固醇安全性、成瘾和戒断的综述。
Clin Drug Investig. 2021 Oct;41(10):835-842. doi: 10.1007/s40261-021-01072-z. Epub 2021 Aug 18.
10
Epithelial-Mesenchymal Transition in Atopy: A Mini-Review.特应性疾病中的上皮-间质转化:一篇综述短文
Front Allergy. 2020 Dec;1. doi: 10.3389/falgy.2020.628381. Epub 2020 Dec 18.